£54.50

Malignant Mesothelioma

Price data last checked 21 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£55 today · previous high £55 · all-time low £53

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical
Generating forecast…
£54.50 £52.55 £52.98 £53.40 £53.83 £54.25 £54.68 09 July 2026 26 July 2026 12 August 2026 29 August 2026 16 September 2026

Price Distribution

Price distribution over 70 days • 2 price levels

Days at Price
Current Price
18 days 52 days · current 0 13 26 39 52 £53 £55 Days at Price

Price Analysis

Most common price: £55 (52 days, 74.3%)

Price range: £53 - £55

Price levels: 2 different prices over 70 days

Description

Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos. Although this mineral has been banned for decades in many countries, epidemiologists predict the MM epidemic will last past 2040, raising many concerns in public health given its late diagnosis, dismal prognosis, and lack of current efficient therapies. To deal with this situation, important breakthroughs have recently been made in the understanding of MM's complex biology and the carcinogenic process of the different patterns of the disease. Examples of these include the development of new biomarkers and the deciphering of gene-environment interactions, molecular mechanisms of invasiveness, deregulated pathways, altered expression of miRNAs, DNA damage repair, or metabolic profile. From now on, MM's aggressive and chemoresistant character appears linked to a polyclonal malignancy, and heterogeneity in molecular alterations. Given these improvements, new therapeutic targets are being explored to solve the double challenge faced by clinicians. The first is to reduce tumor development and its wasting consequences as soon as possible, without resistance and with limited toxicity. The second is to stimulate the recognition of tumor cells by the induction of a specific immune response. This Special Issue will highlight all these aspects.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
06 December 2021
Listed Since
21 January 2022

Barcode

No barcode data available

Similar Products You Might Like

Malignant Mesothelioma: 189 (Recent Results in Cancer Research, 189)
87% match

Malignant Mesothelioma: 189 (Recent Results in Cancer Research, 189)

Springer

£103.24 16 Sep 2026
Pathology of Malignant Mesothelioma
83% match

Pathology of Malignant Mesothelioma

Springer

£80.67 16 Sep 2026
Asbestos and Mesothelioma (Current Cancer Research)
83% match

Asbestos and Mesothelioma (Current Cancer Research)

Springer

£92.22 16 Sep 2026
Management of Pancreatic Cancer
80% match

Management of Pancreatic Cancer

£80.06 22 Aug 2026
Oncogenesis of Lymphoma
78% match

Oncogenesis of Lymphoma

£70.75 27 Aug 2026
Melanoma - Standard of Care, Challenges, and Updates in Clinical Research
78% match

Melanoma - Standard of Care, Challenges, and Updates in Clinical Research

IntechOpen

£119.00 31 Aug 2026
Advancements in Lung Cancer Surgical Treatment and Prognosis
78% match

Advancements in Lung Cancer Surgical Treatment and Prognosis

£62.50 23 Aug 2026
Endocrine and Neuroendocrine Cancers
78% match

Endocrine and Neuroendocrine Cancers

£51.92 23 Aug 2026
Multiple Myeloma - a New Era of Treatment Strategies
77% match

Multiple Myeloma - a New Era of Treatment Strategies

£85.29 10 Aug 2026
Novel Therapeutic Approaches for Cancer Treatment
77% match

Novel Therapeutic Approaches for Cancer Treatment

£95.56 22 Aug 2026
Multiple Primary Malignancies (Updates in Surgery)
77% match

Multiple Primary Malignancies (Updates in Surgery)

Springer

£103.27 06 Aug 2026
Advances in Plant-Sourced Natural Compounds as Anticancer Agents
77% match

Advances in Plant-Sourced Natural Compounds as Anticancer Agents

£54.17 22 Aug 2026
Prostate Cancer: Symptoms, Diagnosis & Treatment
77% match

Prostate Cancer: Symptoms, Diagnosis & Treatment

£87.53 22 Aug 2026
New Insights into Endometrial Cancer 2022
76% match

New Insights into Endometrial Cancer 2022

£51.92 23 Aug 2026
Pediatric Cancers
76% match

Pediatric Cancers

£70.80 29 Jul 2026
Malignant Melanoma: Biology, Diagnosis, and Therapy: 43 (Cancer Treatment and Research)
76% match

Malignant Melanoma: Biology, Diagnosis, and Therapy: 43 (Cancer Treatment and Research)

Springer

£122.06 29 Aug 2026
Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
76% match

Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles

£64.27 18 Aug 2026
Lentigo Maligna Melanoma: Challenges in Diagnosis and Management
76% match

Lentigo Maligna Melanoma: Challenges in Diagnosis and Management

Springer

£98.42 04 Aug 2026
Advances in the Diagnosis and Treatment of Thyroid Carcinoma
76% match

Advances in the Diagnosis and Treatment of Thyroid Carcinoma

£57.68 13 Sep 2026
Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)
76% match

Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)

Springer

£129.99 08 Aug 2026
Molecular Targeted Therapy of Lung Cancer
76% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Immunotherapy in Hepatocellular Carcinoma
76% match

Immunotherapy in Hepatocellular Carcinoma

£64.26 22 Aug 2026
Merkel Cell Carcinoma: A Multidisciplinary Approach: 2 (Molecular Medicine And Medicinal Chemistry)
76% match

Merkel Cell Carcinoma: A Multidisciplinary Approach: 2 (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£70.49 05 Aug 2026
Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
76% match

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer

MDPI AG

£64.85 29 Aug 2026